The short answer
Caffeine can raise clozapine blood levels by slowing its breakdown. Keep your caffeine intake consistent and tell your prescriber before making a major change in coffee, energy drinks, tea, or supplements. The amount that matters varies between people. Monitoring or a medication adjustment may be needed; do not change your clozapine dose yourself.
What this answer covers
Caffeine from drinks, foods and supplements during oral clozapine treatment. The studies used different caffeine amounts and do not establish a daily limit that is safe for everyone.
- Supplement or preparation
- Caffeine
- Medication ingredient
- clozapine
Why caffeine can matter
Caffeine can slow the breakdown of clozapine, allowing blood levels to rise. The current clozapine label advises monitoring for adverse reactions when caffeine is used and says a clinician may need to adjust the clozapine dose. This is a matter for the prescribing team, not a reason to change the medication dose yourself.
What the direct studies found
In 12 healthy nonsmoking men given single 12.5 mg clozapine doses, caffeine intake averaging 550 mg daily was associated with 19% higher drug exposure and 14% lower clearance. These were single-dose results in healthy volunteers. A separate small study in hospitalized patients found higher average clozapine levels with caffeinated coffee than with decaffeinated coffee. Its combined analysis found a 20% difference, while the smaller fully compliant subgroup had a statistically uncertain result.
Keep the pattern consistent
There is no required caffeine intake and no fixed daily cutoff that fits everyone. A large change in coffee, energy drinks, tea, or a caffeine-containing product can matter more than one usual serving. Tell the clozapine prescriber before starting, stopping, or making a major change so monitoring and any dose decision can be individualized.
What the severe case can tell us
One case report described severe illness and a clozapine concentration of 1,796 ng/mL after increased energy-drink use in a man taking 400 mg daily. It cannot prove caffeine caused the event because inflammation, other drugs, and alcohol cessation were also present, and the report gives conflicting caffeine details. It is a reason to seek prescriber advice promptly after a major change, not a precise danger threshold.
Evidence and practical considerations
Absorption & effectiveness
Caffeine can increase clozapine blood levels through reduced metabolism or clearance; increased absorption was not established.
- Exact scope
- Caffeine from coffee, energy drinks, tea, and caffeine-containing products. with Clozapine, including single-dose study exposure and treated hospitalized patients.
- Medication form and route
- oral clozapine; oral caffeine-containing beverages or products
- Timing or duration
- Single-dose crossover exposure and seven-day coffee phases; no universal change interval established.
What remains uncertain
- Small studies with different populations and exposures; estimates must not be merged.
Factors that may matter: size and direction of caffeine change; smoking and other medicines; prescriber-directed blood-level monitoring.
Read the supporting source summaries
Source 1: randomized crossover pharmacokinetic study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 12 healthy nonsmoking men.
Clozapine AUC rose 19% and clearance fell 14%; both reported P=.05.
How this applies: Direct caffeine-clozapine pharmacokinetic evidence supporting reduced metabolism or clearance, not increased absorption.
Single-dose healthy-volunteer study, not maintenance clozapine patients; abstract-only access after failed full-text request.
Source 2: coffee-phase patient study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 12 hospitalized patients entered coffee and decaffeinated-coffee seven-day phases; two were excluded. Six fully compliant participants had a separate analysis.
Six fully compliant participants had 26% higher clozapine trough concentrations, not statistically significant (95% CI -3% to 54%, P=.07). Combined data showed 20% higher concentrations (95% CI 3% to 37%, P=.03).
How this applies: Direct patient evidence that a coffee change can alter clozapine concentrations; supports consistency and monitoring.
Do not merge the compliant-subgroup and combined estimates or state that all 12 were analyzed; abstract does not establish a universal caffeine dose threshold.
Source 3: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed clozapine.
Advises monitoring for adverse reactions and considering a clinician-directed clozapine reduction if needed. The one-third dose rule is specified for strong CYP1A2 inhibitors, not caffeine.
How this applies: Direct medication guidance for caffeine changes; strong-inhibitor dose rules are not transferred to caffeine.
Label does not provide a fixed caffeine dose, a universal coffee amount, or an hour-based separation instruction.
Research assessment: · Open full citations ↗
Side effects & toxicity
A major caffeine or energy-drink change can require clinician review during clozapine treatment because blood levels and adverse effects may change.
- Exact scope
- Caffeine, especially changes in concentrated energy-drink use. with Clozapine treatment.
- Medication form and route
- oral clozapine; oral caffeine-containing beverages or products
- Timing or duration
- No fixed caffeine threshold or timing interval is established.
What remains uncertain
- The severe case has major confounding and internally inconsistent exposure details; it cannot prove causality.
Factors that may matter: large change in habitual intake; inflammation; other medicines; alcohol or smoking changes.
Read the supporting source summaries
Source 1: case report
pmc.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Adult man receiving clozapine 400 mg/day.
The report describes intensive-care admission and severe toxicity in temporal association with increased energy-drink use.
How this applies: Signals possible serious risk after a major caffeine or energy-drink change, but cannot quantify individual risk or establish a cutoff.
Causality is not definite. Inflammation, other drugs, and alcohol cessation are confounders. Abstract and body conflict on age (34 versus 35), treatment duration (5 years versus 2 years), and caffeine exposure (600 mg/day versus 150-450 mg/day); no precise harmful threshold can be selected.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed clozapine.
Advises monitoring for adverse reactions and considering a clinician-directed clozapine reduction if needed. The one-third dose rule is specified for strong CYP1A2 inhibitors, not caffeine.
How this applies: Direct medication guidance for caffeine changes; strong-inhibitor dose rules are not transferred to caffeine.
Label does not provide a fixed caffeine dose, a universal coffee amount, or an hour-based separation instruction.
Source 3: randomized crossover pharmacokinetic study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 12 healthy nonsmoking men.
Clozapine AUC rose 19% and clearance fell 14%; both reported P=.05.
How this applies: Direct caffeine-clozapine pharmacokinetic evidence supporting reduced metabolism or clearance, not increased absorption.
Single-dose healthy-volunteer study, not maintenance clozapine patients; abstract-only access after failed full-text request.
Source 4: coffee-phase patient study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 12 hospitalized patients entered coffee and decaffeinated-coffee seven-day phases; two were excluded. Six fully compliant participants had a separate analysis.
Six fully compliant participants had 26% higher clozapine trough concentrations, not statistically significant (95% CI -3% to 54%, P=.07). Combined data showed 20% higher concentrations (95% CI 3% to 37%, P=.03).
How this applies: Direct patient evidence that a coffee change can alter clozapine concentrations; supports consistency and monitoring.
Do not merge the compliant-subgroup and combined estimates or state that all 12 were analyzed; abstract does not establish a universal caffeine dose threshold.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Private package prepared without clinical approval or release. | |
| Research summary published |
Article revision: d7966dc0759f97b8
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.